Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v2-FR
Language English French
Date Updated 2022-07-26 2021-11-10
Drug Identification Number 02332477 02332477
Brand name AURALGAN AURALGAN
Common or Proper name BENZOCAINE BENZOCAINE
Company Name PALADIN PHARMA INC. PALADIN PHARMA INC.
Ingredients ANTIPYRINE BENZOCAINE ANTIPYRINE BENZOCAINE
Strength(s) 54MG 14MG 54MG 14MG
Dosage form(s) SOLUTION SOLUTION
Route of administration OTIC OTIC OTIC OTIC
Packaging size 14mL 14mL
ATC code S02DA S02DA
ATC description OTHER OTOLOGICALS OTHER OTOLOGICALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-02 2021-11-02
Estimated end date 2022-08-01 2021-11-30
Actual end date 2022-07-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Discontinued
Health Canada comments